Stock Rich List
#699 on the corporate holders of 809 holders

Decheng Capital Global Life Sciences Fund IV, L.P.

10% owner at CG Oncology; 10% owner at Aardvark Therapeutics.

$76.2M
in disclosed stock, +$1.8M (+2.38%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
699th of 809
Companies held
1
Largest holding
CGON, 100.0% of total
Latest SEC filing
Feb 14, 2025
Listed but not counted
$3.9M

What the $76.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
CG Oncology CGON
Common Stock
Directly930,612$81.90$76.2M100.0%Form 3, Jan 24, 2024

Share counts are the amounts Decheng Capital Global Life Sciences Fund IV, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Decheng Capital Global Life Sciences Fund IV, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Aardvark Therapeutics AARD
Common Stock
Through Decheng Capital Global Life Sciences Fund IV, L.P.
Held by a company or fund the insider manages
2,958,887$1.00$3.0M—Form 4, Feb 14, 2025
Aardvark Therapeutics AARD
Common Stock
Through Decheng Capital Global Healthcare Fund (Master), LP
Held by a company or fund the insider manages
958,412$1.00$958K—Form 4, Feb 14, 2025

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
696L-5 Healthcare Partners, LLC
10% owner, Alphatec Holdings
$76.5M−$1.8M (−2.27%)
697Insight Venture Partners (Delaware) X, L.P.
Director, nCino
$76.4M−$3.9M (−4.87%)
698Ziff Davis, Inc.
10% owner, Consensus Cloud Solutions
$76.3M−$3.9M (−4.82%)
699Decheng Capital Global Life Sciences Fund IV, L.P.
10% owner, CG Oncology
$76.2M+$1.8M (+2.38%)
700Fifth Era Management Sponsor I LLC
10% owner, Fifth Era Acquisition Corp I
$75.6M−$142K (−0.19%)
701Hcn LP
Director, NextDecade
$75.0M−$1.8M (−2.30%)
702James R Scott Trust, James R Scott & First Interstate Wealth Management Co-TTEEs
10% owner, First Interstate BancSystem
$74.8M−$1.2M (−1.63%)

Other CG Oncology insiders

All CGON insiders

Questions

How much stock does Decheng Capital Global Life Sciences Fund IV, L.P. own?

Decheng Capital Global Life Sciences Fund IV, L.P. holds $76,217,123 in listed stock based on SEC filings and current prices, mostly CG Oncology (CGON). That ranks 699th on the Stock Rich List.

Is this Decheng Capital Global Life Sciences Fund IV, L.P.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with Xiangmin Cui.